Literature DB >> 32979117

Performance of cochlear implant recipients fitted with triphasic pulse patterns.

Salman F Alhabib1, Yassin Abdelsamad2, Medhat Yousef3,4, Farid Alzhrani3.   

Abstract

PURPOSE: To assess the effect of triphasic pulse pattern stimulation strategy on the audiological performance of cochlear implant recipients with unintended facial nerve stimulation (FNS), and to compare the audiological and speech outcomes before and after switching to triphasic stimulation.
METHODS: A retrospective study of patients who have changed their fitting maps from biphasic to triphasic pulse pattern stimulation because of FNS after cochlear implantation (CI). All identified patients with FNS after CI from 2017 to 2019 were included in this study. The medical records of 11 patients (16 ears) were queried for demographic and radiological data, pure tone audiometry, speech reception thresholds, speech discrimination score at 65 dB, maximum comfortable levels, thresholds, and dynamic range. Then, these parameters were compared in the two conditions, biphasic and triphasic.
RESULTS: Using triphasic pulse stimulation only or combined with switch-off of few channels, complete resolution of FNS was achieved. Triphasic pulse pattern stimulation was associated with better speech discrimination scores (75.25 ± 26.13%) compared to the biphasic pulse (58.25 ± 26.13%). This triphasic strategy also showed higher maximum comfortable levels (36.62 ± 1.63 qu) than biphasic strategy (31.58 ± 2.5 qu). Moreover, the dynamic range was wider using triphasic pulse strategy. In general, the triphasic pulse pattern resulted in successful suppression of facial nerve stimulation with suitable maximum comfortable levels and better speech discrimination.
CONCLUSION: Triphasic pulse pattern stimulation is an appropriate tool in controlling FNS following cochlear implantation with wider dynamic range. We recommend that all patients with facial nerve stimulation after CI surgery be switched to a triphasic pulse program prior to considering further surgery.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cochlear implant; Facial nerve stimulation; Speech perception; Triphasic pulse stimulation

Year:  2020        PMID: 32979117     DOI: 10.1007/s00405-020-06382-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  5 in total

1.  The facial nerve canal: an important cochlear conduction path revealed by Clarion electrical field imaging.

Authors:  Filiep Vanpoucke; Andrzej Zarowski; Jan Casselman; Johan Frijns; Stefaan Peeters
Journal:  Otol Neurotol       Date:  2004-05       Impact factor: 2.311

2.  Investigating Facial Nerve Stimulation After Cochlear Implantation in Adult and Pediatric Recipients.

Authors:  Farid Alzhrani; Roa Halawani; Sundus Basodan; Rawan Hudeib
Journal:  Laryngoscope       Date:  2020-03-28       Impact factor: 3.325

3.  Facial nerve stimulation after Nucleus 22-channel cochlear implantation.

Authors:  D C Kelsall; J K Shallop; T G Brammeier; E C Prenger
Journal:  Am J Otol       Date:  1997-05

Review 4.  Facial nerve stimulation from cochlear implants.

Authors:  D C Bigelow; D J Kay; K O Rafter; M Montes; G W Knox; D M Yousem
Journal:  Am J Otol       Date:  1998-03

5.  Facial nerve stimulation after cochlear implantation: our experience.

Authors:  S Berrettini; De A Vito; L Bruschini; S Passetti; F Forli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-02       Impact factor: 2.124

  5 in total
  2 in total

1.  Cochlear implantation among patients with otosclerosis: a systematic review of clinical characteristics and outcomes.

Authors:  Majed Assiri; Tawfiq Khurayzi; Afrah Alshalan; Abdulrahman Alsanosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-08-17       Impact factor: 2.503

Review 2.  Cochlear implantation in common cavity deformity: a systematic review.

Authors:  Ayshah Al-Mahboob; Salman F Alhabib; Yassin Abdelsamad; Farid Alzhrani
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-29       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.